Frazier Healthcare Partners Adds Highly Experienced Pharma Executive to Growth Buyout Team
Frazier Healthcare Partners, a private equity firm focused on healthcare, has announced that Willis Chandler has joined their Growth Buyout team as an Executive in Residence. Chandler will help develop and execute investment strategies in pharma and pharmacy services, focusing on sourcing, diligence, and leadership of a new platform investment.
Chandler brings extensive experience, having most recently served as President of Global Pharma Services at Cencora (NYSE: COR), where he led a multi-billion dollar business unit with 10,000 employees. His background includes leadership roles at CVS Health and co-founding Shields Specialty Pharmacy. Chandler's expertise in entrepreneurial leadership, commercial transformation, and acquisition integration is expected to be valuable in Frazier's efforts to invest in disruptive growth-oriented healthcare companies.
Frazier Healthcare Partners, una societ脿 di private equity focalizzata sulla sanit脿, ha annunciato che Willis Chandler 猫 entrato a far parte del loro team di Growth Buyout come Executive in Residence. Chandler aiuter脿 a sviluppare ed eseguire strategie di investimento in farmaci e servizi farmaceutici, concentrandosi sulla ricerca, la due diligence e la leadership di un nuovo investimento di piattaforma.
Chandler porta con s茅 un'esperienza significativa, avendo recentemente ricoperto il ruolo di Presidente dei Global Pharma Services presso Cencora (NYSE: COR), dove ha guidato una divisione aziendale da miliardi di dollari con 10.000 dipendenti. Il suo percorso include ruoli dirigenziali presso CVS Health e la co-fondazione di Shields Specialty Pharmacy. Si prevede che l'expertise di Chandler nella leadership imprenditoriale, nella trasformazione commerciale e nell'integrazione delle acquisizioni sar脿 preziosa negli sforzi di Frazier per investire in aziende sanitarie orientate alla crescita e al cambiamento.
Frazier Healthcare Partners, una firma de capital privado enfocada en el cuidado de la salud, ha anunciado que Willis Chandler se ha unido a su equipo de Growth Buyout como Ejecutivo en Residencia. Chandler ayudar谩 a desarrollar y ejecutar estrategias de inversi贸n en f谩rmacos y servicios farmac茅uticos, centr谩ndose en la b煤squeda, la diligencia debida y el liderazgo de una nueva inversi贸n en plataforma.
Chandler aporta una amplia experiencia, habiendo ocupado recientemente el cargo de Presidente de Global Pharma Services en Cencora (NYSE: COR), donde lider贸 una unidad de negocios multimillonaria con 10,000 empleados. Su trayectoria incluye roles de liderazgo en CVS Health y la co-fundaci贸n de Shields Specialty Pharmacy. Se espera que la experiencia de Chandler en liderazgo emprendedor, transformaci贸n comercial e integraci贸n de adquisiciones sea valiosa en los esfuerzos de Frazier por invertir en empresas de atenci贸n m茅dica orientadas al crecimiento disruptivo.
Frazier Healthcare Partners電� 鞚橂鞐� 齑堨爯鞚� 毵烄稑 靷韼�霌� 須岇偓搿�, Willis Chandler臧� Growth Buyout 韺�鞚� Executive in Residence搿� 頃╇頄堧嫟瓿� 氚滍憸頄堨姷雼堧嫟. Chandler電� 鞝滌暯 氚� 鞎疥淡 靹滊箘鞀�鞐愳劀 韴瀽 鞝勲灥鞚� 臧滊皽頃橁碃 鞁ろ枆頃橂姅 雿� 霃勳泙鞚� 欷� 鞓堨爼鞚措┌ 鞁犼窚 頂岆灚韽� 韴瀽鞚� 靻岇嫳, 鞁れ偓 氚� 毽崝鞁棎 歆戩頃� 瓴冹瀰雼堧嫟.
Chandler電� 斓滉芳 Cencora (NYSE: COR)鞐愳劀 旮�搿滊矊 鞝滌暯 靹滊箘鞀れ潣 靷灔鞙茧 鞛頃橂┌ 10,000氇呾潣 歆侅洂鞚� 霊� 靾橃嫮鞏� 雼煬 攴滊鞚� 牍勳雼堨姢 鞙犽嫑鞚� 鞚措亴鞏� 鞓� 靸侂嫻頃� 瓴巾棙鞚� 臧�歆�瓿� 鞛堨姷雼堧嫟. 攴胳潣 瓴诫牓鞐愲姅 CVS Health鞚� 毽崝鞁� 鞐暊瓿� Shields Specialty Pharmacy 瓿惦彊 靹る鞚� 韽暔霅╇媹雼�. Chandler鞚� 旮办梾臧�鞝� 毽崝鞁�, 靸侅梾鞝� 氤�頇� 氚� 鞚胳垬 韱淀暕鞐� 雽�頃� 鞝勲 歆�鞁濎潃 Frazier臧� 順侅嫚鞝侅澑 靹膘灔 歆�頄� 鞚橂 旮办梾鞐� 韴瀽頃橂牑電� 雲鸽牓鞐� 鞙犾毄頃� 瓴冹溂搿� 旮半寑霅╇媹雼�.
Frazier Healthcare Partners, une soci茅t茅 de capital-investissement sp茅cialis茅e dans le secteur de la sant茅, a annonc茅 que Willis Chandler a rejoint leur 茅quipe de Growth Buyout en tant qu'Executive in Residence. Chandler aidera 脿 d茅velopper et 脿 ex茅cuter des strat茅gies d'investissement dans le secteur pharmaceutique et les services pharmaceutiques, en se concentrant sur la recherche, la diligence raisonnable et la direction d'un nouvel investissement plateforme.
Chandler apporte une vaste exp茅rience, ayant r茅cemment occup茅 le poste de Pr茅sident des Global Pharma Services chez Cencora (NYSE: COR), o霉 il a dirig茅 une unit茅 commerciale de plusieurs milliards de dollars comptant 10 000 employ茅s. Son parcours inclut des r么les de leadership chez CVS Health et la co-fondation de Shields Specialty Pharmacy. L'expertise de Chandler en mati猫re de leadership entrepreneurial, de transformation commerciale et d'int茅gration des acquisitions devrait 锚tre pr茅cieuse dans les efforts de Frazier pour investir dans des entreprises de sant茅 novatrices ax茅es sur la croissance.
Frazier Healthcare Partners, eine Private-Equity-Firma, die sich auf das Gesundheitswesen konzentriert, hat bekannt gegeben, dass Willis Chandler ihrem Growth Buyout-Team als Executive in Residence beigetreten ist. Chandler wird dabei helfen, Investitionsstrategien in Pharma und Apothekenangebote zu entwickeln und umzusetzen, wobei der Schwerpunkt auf der Beschaffung, Due Diligence und F眉hrung einer neuen Plattforminvestition liegt.
Chandler bringt umfangreiche Erfahrung mit, nachdem er zuletzt als Pr盲sident der Global Pharma Services bei Cencora (NYSE: COR) t盲tig war, wo er eine milliardenschwere Gesch盲ftseinheit mit 10.000 Mitarbeitern leitete. Sein Werdegang umfasst F眉hrungspositionen bei CVS Health und die Mitbegr眉nderrolle der Shields Specialty Pharmacy. Chandlers Expertise in unternehmerischer F眉hrung, kommerzieller Transformation und Integrationsakquisitionen wird als wertvoll f眉r die Bem眉hungen von Frazier erachtet, in disruptive wachstumsorientierte Gesundheitsunternehmen zu investieren.
- Addition of experienced pharma executive Willis Chandler to the Growth Buyout team
- Focus on expanding investments in the growing pharma and pharmacy services sector
- Chandler's extensive leadership experience in multi-billion dollar business units
- Potential for identifying and investing in disruptive growth-oriented healthcare companies
- None.
鈥淭he secular growth in pharma and pharmacy services has been an area of focus for Frazier for several years, and we are thrilled to welcome an industry veteran like Willis to our team,鈥� said Nathan Every, General Partner at Frazier. 鈥淲e are confident that his extensive leadership experience will be of great value as we partner with him to invest in this space.鈥�
鈥淚 have long admired the way Frazier鈥檚 Growth Buyout team approaches sourcing and growing promising healthcare companies, and I am thrilled to be joining this great team,鈥� said Mr. Chandler. 鈥淚 am excited to work alongside Frazier to identify and work with disruptive growth-oriented healthcare companies.鈥�
Mr. Chandler was most recently the President of Global Pharma Services at Cencora (NYSE: COR; f.k.a. Amerisource Bergen), where he led the multi-billion dollar business unit with 10,000 employees. Prior to his role leading the global pharma services segment, Mr. Chandler was Cencora鈥檚 President of Health System, Specialty, Government, and Commercial Solutions where he led all distribution and services into health systems and specialist facilities. Prior to Cencora, Mr. Chandler was the VP of Health System Alliances at CVS Health, and before that, he was the co-founder of Shields Specialty Pharmacy, a national leader in specialty pharmacy services for hospitals and health systems. Across his roles, Mr. Chandler has a demonstrated history of entrepreneurial leadership, commercial transformation, and acquisition integration.
About Frazier Healthcare Partners:
Founded in 1991, Frazier Healthcare Partners is a private equity firm focused exclusively on the healthcare industry. Since its inception, Frazier has raised over
For more information about Frazier Healthcare Partners, visit .
View source version on businesswire.com:
Frazier Healthcare Partners
Carol Eckert, VP of Investor Relations
Phone: 206.621.7200
Email: carol.eckert@frazierhealthcare.com
Source: Frazier Healthcare Partners
FAQ
Who is Willis Chandler and what role has he taken at Frazier Healthcare Partners?
What was Willis Chandler's most recent position before joining Frazier Healthcare Partners?
How does Frazier Healthcare Partners plan to utilize Willis Chandler's experience?
What is the significance of Willis Chandler joining Frazier Healthcare Partners for the company's investment strategy?
